quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:36:50·386d
INSIDERFiling
Sandy Spring Bancorp Inc. logo

Director Lemek Brian J returned 256,915 shares to the company, closing all direct ownership in the company (SEC Form 4)

SASR· Sandy Spring Bancorp Inc.
Finance
Original source

Companies

  • SASR
    Sandy Spring Bancorp Inc.
    Finance

Recent analyst ratings

  • Mar 1UpdateJanney$25.00
  • Oct 2UpdateDA Davidson$22.00
  • Apr 4UpdateStephens$28.00
  • Dec 5UpdatePiper Sandler$39.00
  • Apr 22UpdateKeefe Bruyette$50.00
  • Mar 22UpdateDA Davidson$61.00

Related

  • SEC371d
    Amendment: SEC Form SCHEDULE 13G/A filed by Sandy Spring Bancorp Inc.
  • SEC378d
    SEC Form 15-12G filed by Sandy Spring Bancorp Inc.
  • INSIDER385d
    Amendment: SEC Form 4 filed by Director Cook Kenneth C
  • INSIDER385d
    President & CEO Schrider Daniel J returned 220,343 shares to the company and was granted 15,625 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    EVP, Chief Information Officer Sadowski John D returned 47,034 shares to the company and was granted 3,386 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    EVP, Consumer Banking Pulford Susan Lynne returned 41,673 shares to the company and was granted 4,063 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    Executive Vice President O'Brien Joseph J Jr was granted 7,227 shares and returned 115,362 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    EVP, Chief Operations Officer Mcdowell Ronda M was granted 3,447 shares and returned 42,178 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022